Clearance Summary
Rafugen DBM received FDA 510(k) clearance under submission number K180121, sponsored by Cellumed Co., Ltd.. The device was reviewed via the Traditional premarket notification pathway and assigned to the Orthopedic review panel. The statutory decision date of record is 2018-04-11.
- Submission: K180121
- Applicant / Sponsor: Cellumed Co., Ltd.
- Clearance pathway: Traditional
- Review panel: Orthopedic
- Device class: Class II
- Regulation citation: 21 CFR 888.3045
- Decision date: 2018-04-11
Classification & Regulation
This clearance is catalogued under FDA product code MQV and 21 CFR 888.3045, within the Orthopedic review panel as a Class II device.